Sub menu

 
 

3.3. Final decision in relation to broflanilide

Scheduling of chemicals and poisons
Last updated

3. Advisory Committee on Chemicals Scheduling (ACCS #25) - Final decisions made pursuant to regulation 42ZCZR

3.3. Final decision in relation to broflanilide

Final decision

Pursuant to regulation 42ZCZR of the Regulations, a Delegate of the Secretary has made a final decision to confirm the interim decision and amend the current Poisons Standard in relation to broflanilide as follows:

Schedule 6 - New Entry

BROFLANILIDE except when included in Schedule 5.

Schedule 5 - New Entry

BROFLANILIDE in preparations containing 0.3 per cent or less of broflanilide.

INDEX - New Entry

BROFLANILIDE

Schedule 6
Schedule 5

Date of effect of the decision

1 February 2020.

Reasons for the final decision (including findings on material questions of fact)

I have made a final decision to confirm my interim decision to include broflanilide in Schedules 5 and 6 of the Poisons Standard. I note that no public submissions were received before the second closing date in response to the call for further submissions published on 12 September 2019 under regulation 42ZCZP of the Regulations.

Public submissions in response to the interim decision

No public submissions were received in response to the interim decision.

This webpage on the TGA website was printed on 10 Sep 2024. Printed content may be out of date. For up-to-date information, always refer to the digital version: https://www.tga.gov.au/resources/publication/scheduling-decisions-final/notice-final-decisions-amend-or-not-amend-current-poisons-standard-november-2019/33-final-decision-relation-broflanilide

Help us improve the Therapeutic Goods Administration site